Moretto R, Elliott A, Rossini D, Intini R, et al. Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter? Br J Cancer 2022 Jun 3. pii: 10.1038/s41416-022-01852.
PMID: 35665778